February 8, 2025 - 08:15

Montgomery County officials are alarmed by reports suggesting that a new executive order from the Trump administration may lead to the dismissal of thousands of federal health workers. This potential move has raised significant concerns among local leaders, who fear the impact it could have on public health services and the workforce.
The proposed order has sparked discussions about the future of health care in the region, with officials emphasizing the critical role that federal health workers play in managing health crises and providing essential services. The possibility of widespread layoffs could strain resources and hinder ongoing public health initiatives, particularly in light of recent health challenges.
Local leaders are calling for clarity and urging the administration to reconsider any actions that could jeopardize the stability of federal health agencies. They stress that maintaining a robust workforce is essential for ensuring the health and safety of the community. As the situation develops, officials remain vigilant in advocating for the rights and jobs of health workers.
November 1, 2025 - 03:51
Tammy Derk Appointed Vice President of Children's Services at Penn State HealthPenn State Health has appointed Tammy Derk as the new administrative vice president of its Children’s services, marking a significant leadership change within the organization. With over 30 years...
October 31, 2025 - 01:14
Honoring the Champions of Public HealthAt the 2025 Awards Gala and Silent Auction, the National Foundation for Infectious Diseases celebrated the remarkable contributions of three distinguished public health champions: Anne E. Goldfeld,...
October 30, 2025 - 08:19
Major Reductions in Federal Mental Health and Addiction Agency Under Trump AdministrationThe Trump administration has significantly diminished the federal agency responsible for mental health and addiction treatment, leading to a reduction of its workforce by over 50%. This drastic cut...
October 29, 2025 - 18:25
Federal Regulators Aim to Lower Costs of Biotech MedicationsFederal regulators are taking significant steps to facilitate the development of more affordable alternatives to essential biotech drugs that millions of Americans rely on for treating serious...